Kitch Wilson
Private Equity Investor at Pioneer Fund/NY/
Profile
Kitch Wilson is a professional who has worked as an Advisor at Bell Biosystems, Inc. from 2011 to 2014.
Currently, he is a Venture Partner at Pioneer Fund since 2023.
Mr. Wilson has a graduate degree from Stanford University and Duke University School of Medicine.
Kitch Wilson active positions
| Companies | Position | Start |
|---|---|---|
Pioneer Fund/NY/
 Pioneer Fund/NY/ Investment ManagersFinance Pioneer Fund/NY/ is a venture capital firm founded by Jason Gray. The firm is headquartered in San Francisco, California. | Private Equity Investor | 01/10/2023 |
Former positions of Kitch Wilson
| Companies | Position | End |
|---|---|---|
Bell Biosystems, Inc.
 Bell Biosystems, Inc. BiotechnologyHealth Technology Bell Biosystems, Inc. operates as a synthetic biology company. It develops Magnelle, a synthetic organelle that produces magnetic nanoparticles from intracellular iron, as well as enables to track, control, and destroy transplanted cells in vivo. The firm's product is used in regenerative medicine, oncology, and other cell-based fields. The company was founded by Caleb B. Bell III and Daniel Bell in June 2009 and is headquartered in San Francisco, CA. | Consultant / Advisor | 01/04/2014 |
Training of Kitch Wilson
| Stanford University | Graduate Degree |
| Duke University School of Medicine | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 2 |
|---|---|
Pioneer Fund/NY/
Pioneer Fund/NY/ Investment ManagersFinance Pioneer Fund/NY/ is a venture capital firm founded by Jason Gray. The firm is headquartered in San Francisco, California. | Finance |
Bell Biosystems, Inc.
Bell Biosystems, Inc. BiotechnologyHealth Technology Bell Biosystems, Inc. operates as a synthetic biology company. It develops Magnelle, a synthetic organelle that produces magnetic nanoparticles from intracellular iron, as well as enables to track, control, and destroy transplanted cells in vivo. The firm's product is used in regenerative medicine, oncology, and other cell-based fields. The company was founded by Caleb B. Bell III and Daniel Bell in June 2009 and is headquartered in San Francisco, CA. | Health Technology |
- Stock Market
- Insiders
- Kitch Wilson
